Data / New clinical trials / Dry Eye Syndromes
Dry Eye Syndromes trials: 235 new since Nov 2024
The full list. New Dry Eye Syndromes clinical trials: 235 rows for $11.75, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 10 rows a month. The new rows come each week by email, $19 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/dry-eye-syndromes, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
235 clinical studies in Dry Eye Syndromes were first posted on ClinicalTrials.gov from November 13, 2024 to November 9, 2026; 61 have an industry sponsor and 128 are recruiting or about to. The newest, NCT07926594, was posted on November 9, 2026: Effectiveness Study of TRYPTYR in Dry Eye Disease (Scott & Christie and Associates, PC).
The request: Every new Dry Eye Syndromes clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 235New trials
- 61Industry sponsored
- 128Recruiting or not yet
- November 9, 2026Latest posted
Newest trials
The newest 100 of 235, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 9, 2026 | NCT07926594 | Effectiveness Study of TRYPTYR in Dry Eye Disease | Scott & Christie and Associates, PC | Observational | Recruiting | Dry Eye Disease | 100 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07919223 | Vitamin B Complex as Adjunct Therapy for Moderate-to-Severe Dry Eye Disease | Rania Fahmy | Not applicable | Completed | Dry Eye Disease, Dry Eye | 56 | Saudi Arabia | clinicaltrials.gov |
| November 3, 2026 | NCT07911930 | LacriFill Canalicular Occlusion for Dry Eye After LASIK | Mann Eye Institute | Not applicable | Not yet recruiting | Dry Eye Syndrome | 75 | United States | clinicaltrials.gov |
| November 2, 2026 | NCT07908251 | a Novel siRNA Eyedrops for DED Treatment | Eye & ENT Hospital of Fudan University | Early phase 1 | Not yet recruiting | Dry Eye | 30 | clinicaltrials.gov | |
| October 29, 2026 | NCT07904728 | Treating Contact Lens Discomfort With Cyclosporine 0.1% Ophthalmic Solution | Ocular Aesthetics, LLC dba Ocular Clinical Trials | Not applicable | Recruiting | Dry Eye Disease (DED), Contact Lens Discomfort (CLD) | 50 | United States | clinicaltrials.gov |
| October 29, 2026 | NCT07902687 | A Clinical Study to Evaluate the Safety and Effectiveness of MSCohi-O Lens in the Treatment of Immune-related Ocular Surface Diseases. | Guangdong ProCapZoom Biosciences Co., Ltd. | Phase 1 | Not yet recruiting | Keratitis, Autoimmunity, Dry Eye Disease (DED) | 20 | clinicaltrials.gov | |
| October 28, 2026 | NCT07901647 | Evaporative Dry Eye | Southern College of Optometry | Phase 4 | Not yet recruiting | Dry Eye, Evaporative Dry Eye, Evaporative Dry Eye Disease | 41 | United States | clinicaltrials.gov |
| October 27, 2026 | NCT07896395 | 20-20-20 Rule Plus Artificial Tears for Dry Eye | Zagazig University | Not applicable | Completed | Dry Eye | 48 | Egypt | clinicaltrials.gov |
| October 26, 2026 | NCT07895849 | Performance Evaluation of the OCUTOP Hand-held Corneal Topographer | University of Plymouth | Not applicable | Not yet recruiting | Corneal Topography, Dry Eye Syndromes, Keratoconus, Healthy Volunteers | 150 | United Kingdom | clinicaltrials.gov |
| October 22, 2026 | NCT07888452 | Cooling Eyedrops for Dry Eye | University of California, Berkeley | Phase 4 | Not yet recruiting | Dry Eye | 50 | United States | clinicaltrials.gov |
| October 14, 2026 | NCT07873931 | A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases | Bristol-Myers Squibb | Phase 1 | Not yet recruiting | Systemic Lupus Erythematosus, Sjögren's Disease, Rheumatoid Arthritis, Idiopathic Inflammatory Myopathies, Systemic... | 60 | Belgium, France, Germany, Netherlands, Poland, United States | clinicaltrials.gov |
| October 14, 2026 | NCT07873697 | Association Between Periodontitis and Dry Eye Disease: A Cross-Sectional Study | University of Sulaimani | Observational | Recruiting | Periodontitis, Dry Eye Disease (DED) | 80 | Iraq | clinicaltrials.gov |
| October 9, 2026 | NCT07868965 | Evaluation of Ophtholic Ultra for Ocular Surface Protection After Cataract Surgery | Kazakh Eye Research Institute | Phase 4 | Active not recruiting | Dry Eye Disease (DED) | 60 | Kazakhstan | clinicaltrials.gov |
| October 1, 2026 | NCT07852234 | Exploratory Study on the Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Moderate to Severe Primary Sjögren's Syndrome | Beijing Tongren Hospital | Phase 2 | Not yet recruiting | Primary Sjögren's Syndrome (pSS) | 12 | China | clinicaltrials.gov |
| September 30, 2026 | NCT07849803 | Effect of Acoltremon Ophthalmic Solution 0.003% on Tear Production and Symptoms in Patients With Tear Deficiency and Concurrent Neuropathic... | University of South Florida | Phase 4 | Not yet recruiting | Ocular Pain, Dry Eye | 28 | United States | clinicaltrials.gov |
| September 30, 2026 | NCT07848373 | Contact Lens-Wearing Dry Eye Subjects Who Are Treated With Acoltremon 0.003% | Eye Research Associates, LLC | Phase 4 | Not yet recruiting | Dry Eye, Contact Lens Discomfort, Eye Drops | 50 | clinicaltrials.gov | |
| September 28, 2026 | NCT07845357 | Switching From Preserved Glaucoma Therapy to Preservative-Free ZOLYMBUS | Southern College of Optometry | Phase 4 | Not yet recruiting | Eye Drops Self-instillation, Glaucoma, Dry Eye | 40 | clinicaltrials.gov | |
| September 28, 2026 | NCT07844408 | Study of Eye Fatigue From Digital Screens and Its Impact on Visual Performance in People With Normal Vision and Myopia, With and Without... | Essilor International | Not applicable | Not yet recruiting | Myopia, Dry Eye Disease (DED) | 120 | France | clinicaltrials.gov |
| September 25, 2026 | NCT07842536 | Efficacy of Lycium Barbarum Polysaccharide in Dry Eye Disease Management | The Hong Kong Polytechnic University | Not applicable | Recruiting | Dry Eye Syndromes | 30 | Hong Kong | clinicaltrials.gov |
| September 25, 2026 | NCT07841912 | Ocular Surface Disease in Glaucoma Patients on Long-Term Therapy | Assiut University | Observational | Not yet recruiting | Glaucoma, Ocular Surface Disease, Dry Eye | 55 | clinicaltrials.gov | |
| September 11, 2026 | NCT07816419 | Yogic Eye Exercises for Computer Vision Syndrome in Female Design Students | King Saud University | Not applicable | Completed | Computer Vision Syndrome, Asthenopia, Eye Strain, Dry Eye, Neck Pain, Shoulder Pain, Back Pain | 36 | Saudi Arabia | clinicaltrials.gov |
| September 9, 2026 | NCT07810972 | Evaluate the Safety and Efficacy of TJO-087 | Taejoon Pharmaceutical Co., Ltd. | Phase 2 | Active not recruiting | Dry Eye Syndrome (DES) | 90 | South Korea | clinicaltrials.gov |
| September 9, 2026 | NCT07810569 | Ocular Surface Changes and Meibomian Gland Dysfunction in Rheumatologic Patients | Assiut University | Observational | Not yet recruiting | Meibomian Gland Dysfunction, Dry Eye Syndromes, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjogren's Syndrome... | 150 | clinicaltrials.gov | |
| September 9, 2026 | NCT07809022 | Temporary Tear Duct Filling With Hyaluronic Acid Gel and Assessment of Dry Eye Disease (DED) After Bilateral Cataract Surgery | Medical University of Vienna | Phase 4 | Not yet recruiting | Dry Eye, Dry Eye Disease (DED), Dry Eye Sensation After Cataract Surgery | 25 | Austria | clinicaltrials.gov |
| September 8, 2026 | NCT07806240 | Safety and Efficacy Study of RTP-008 (an Absorbable Tacrolimus Lacrimal Canalicular Plug) for Dry Eye | Zhejiang Raytone Bioscience Co.,Ltd | Not applicable | Completed | Dry Eye Disease (DED) | 40 | China | clinicaltrials.gov |
| September 1, 2026 | NCT07796178 | Evaluation of Lacrifill | Eye Research Associates, LLC | Phase 4 | Recruiting | Dry Eye, Ocular Surface Disease, Cataract Surgery, Eyes Dry Feeling of | 40 | United States | clinicaltrials.gov |
| August 28, 2026 | NCT07793344 | Four-Week Ocular-Surface Evaluation of an Experimental Ophthalmic Liposomal Nanocarrier in Dry Eye Disease | Regional Specialist Hospital in Wroclaw | Not applicable | Completed | Dry Eye Disease | 26 | Poland | clinicaltrials.gov |
| August 27, 2026 | NCT07790211 | BL-RX01-TFSTAB-1402 | Vance Thompson Vision | Phase 4 | Recruiting | Dry Eye | 20 | United States | clinicaltrials.gov |
| August 27, 2026 | NCT07789054 | Ocular Surface Disease Index and Dry Eye Parameters in Hand Osteoarthritis | Medipol University | Observational | Completed | Dry Eye Syndrome (DES), Hand Osteoarthritis | 23 | Turkey (Türkiye) | clinicaltrials.gov |
| August 24, 2026 | NCT07780890 | A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and Diseases | Massachusetts General Hospital | Observational | Recruiting | Fuchs Endothelial Corneal Dysfunction, Open Angle Glaucoma (OAG), Dry Eye Disease (DED), Keratoconus, Lasik Eye Surgery | 90 | United States | clinicaltrials.gov |
| August 21, 2026 | NCT07778888 | BL1107 Response and Intensity Guided Dosing for Hyperemia Resolution Trial | Bausch & Lomb Incorporated | Phase 2 | Not yet recruiting | Dry Eye Disease | 20 | clinicaltrials.gov | |
| August 19, 2026 | NCT07773740 | Autologous Plasma Rich in Growth Factors for Severe Dry Eye Disease | Gladys Lucia Silva Linares | Not applicable | Not yet recruiting | Dry Eye Disease With Severe Keratitis | 100 | clinicaltrials.gov | |
| August 17, 2026 | NCT07768735 | UNITY DX Cornea Study | Alcon Research | Observational | Recruiting | Tomography | 110 | United States | clinicaltrials.gov |
| August 10, 2026 | NCT07753811 | Effect of Oral Isotretinoin on Ocular Surface and Meibomian Glands | Benha University | Not applicable | Completed | Dry Eye Disease (DED), Meibomian Gland Dysfunction (Disorder), Acne Vulgaris | 60 | Egypt | clinicaltrials.gov |
| August 4, 2026 | NCT07745062 | The Effectiveness of Systane PRO Preservative Free Verses Blink Triple Care Preservative Free | Gordon Schanzlin New Vision | Phase 4 | Recruiting | Dry Eye Disease (DED) | 30 | United States | clinicaltrials.gov |
| July 31, 2026 | NCT07740564 | Phase III Study of OT202 in Treating Moderate to Severe Dry Eye | Ocumension Therapeutics (Suzhou) Co., Ltd | Phase 3 | Recruiting | Dry Eye | 842 | China | clinicaltrials.gov |
| July 28, 2026 | NCT07732010 | TRYPTYR as a Treatment for Patients With Dry Eye Disease (DED) | NYU Langone Health | Phase 4 | Recruiting | Dry Eye Disease (DED) | 50 | United States | clinicaltrials.gov |
| July 23, 2026 | NCT07722650 | Twice-Daily Systane Complete Versus Four-Times-Daily Thealoz Duo for Dry Eye Disease | Instituto Internacional de Medicina y Terapia (IIMET) | Not applicable | Completed | Dry Eye Syndrome (DES), Ocular Surface Disease | 120 | Mexico | clinicaltrials.gov |
| July 23, 2026 | NCT07722624 | A Single Center, Open-Label Study to Evaluate the Ability of the TearScience™ LipiView™ II Ocular Surface Interferometer and the... | The Eye Care Institute | Phase 4 | Active not recruiting | Dry Eye | 20 | United States | clinicaltrials.gov |
| July 20, 2026 | NCT07715266 | POST CATARACT SURGERY DRY EYE DISEASE | NOXELIS | Not applicable | Not yet recruiting | Dry Eye Disease (DED), Cataract Surgery | 33 | Spain | clinicaltrials.gov |
| July 15, 2026 | NCT07706231 | A Study of Full-Spectrum Screen Lighting for Reducing Screen-Related Eye Fatigue and Dry Eye | Zhongshan Ophthalmic Center, Sun Yat-sen University | Not applicable | Not yet recruiting | Visual Fatigue, Dry Eye, Computer Vision Syndrome | 112 | China | clinicaltrials.gov |
| July 15, 2026 | NCT07705893 | Treating Contact Lens Discomfort With Varenicline Solution Nasal Spray 0.03mg | Ocular Aesthetics, LLC dba Ocular Clinical Trials | Not applicable | Recruiting | Dry Eye | 50 | United States | clinicaltrials.gov |
| July 1, 2026 | NCT07679685 | Perfluorohexyloctane Eye Drops vs. Sodium Hyaluronate for Video Display Terminal-Associated Dry Eye | Beijing Tongren Hospital | Phase 4 | Not yet recruiting | Dry Eye | 159 | China | clinicaltrials.gov |
| June 30, 2026 | NCT07676084 | Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops... | Andover Research Eye Institute | Phase 4 | Recruiting | Dry Eye Disease (DED) | 60 | United States | clinicaltrials.gov |
| June 30, 2026 | NCT07675460 | Systemic Isotretinoin Therapy and Eye | Demet Mutlu | Not applicable | Completed | Dry Eye, Choroidal Thickness, Retinal Vascularisation, Acne Cystic, Isotretinoin | 60 | Turkey (Türkiye) | clinicaltrials.gov |
| June 26, 2026 | NCT07671222 | Safety and Efficacy of Topical Infliximab in Autoimmune Dry Eye Disease | Instituto de Oftalmología Fundación Conde de Valenciana | Phase 2 | Not yet recruiting | Sjogren Syndrome, Sjogren Syndrome With Keratoconjunctivitis, Dry Eye Disease (DED) | 38 | Mexico | clinicaltrials.gov |
| June 22, 2026 | NCT07659626 | Long-term Effects of Acoltremon vs. Control in Dry Eye Disease | The Eye Care Institute | Observational | Recruiting | Dry Eye | 60 | United States | clinicaltrials.gov |
| June 18, 2026 | NCT07657858 | Effect of Dry Eye Treatment on Corneal Astigmatism Measurements | Jin Yang | Not applicable | Recruiting | Dry Eye, Cataract | 400 | China | clinicaltrials.gov |
| June 18, 2026 | NCT07656688 | Dose-Finding Study of HUC1-394 in Participants With Dry Eye Disease | Huons Co., Ltd. | Phase 2 | Recruiting | Dry Eye Disease (DED) | 150 | South Korea | clinicaltrials.gov |
| June 16, 2026 | NCT07650708 | A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK | Vance Thompson Vision | Phase 4 | Recruiting | Dry Eye Syndrome (DES), Dry Eye Disease (DED) | 100 | United States | clinicaltrials.gov |
| June 11, 2026 | NCT07640867 | RCI001 Eye Drops 0.25% in Healthy Adult Male Participants | Rudacure | Phase 1 | Completed | Dry Eye | 40 | South Korea | clinicaltrials.gov |
| June 10, 2026 | NCT07639034 | Effectiveness of Systane PRO for Mild to Moderate Dry Eye Disease | Gordon Schanzlin New Vision | Phase 4 | Completed | Dry Eye Disease (DED) | 33 | United States | clinicaltrials.gov |
| June 9, 2026 | NCT07635849 | Randomized Clinical Trial of Artificial Tears With and Without Preservatives in Patients With Dry Eye Disease | Pokhara Academy of Health Sciences, Western Regional Hospital | Phase 4 | Not yet recruiting | Dry Eye Disease (DED) | 80 | Nepal | clinicaltrials.gov |
| June 8, 2026 | NCT07633938 | The Effect of Eyelid Support Plate Assisted Eyelid Massage on Meibomian Gland Dysfunction: a Randomized Controlled Trial | Zhongshan Ophthalmic Center, Sun Yat-sen University | Not applicable | Not yet recruiting | Dry Eye Disease (DED), MGD-Meibomian Gland Dysfunction | 142 | China | clinicaltrials.gov |
| June 8, 2026 | NCT07632534 | Study of Proteomic Factors in Patients With Severe Dry Eye Syndrome Treated With Autologous Serum Eye Drops. | Centre Hospitalier Universitaire de Saint Etienne | Not applicable | Recruiting | Dry Eye Syndrome (DES), Dry Eye | 68 | France | clinicaltrials.gov |
| June 4, 2026 | NCT07625124 | A Phase 2 Study of RCI001 Ophthalmic Solution in Participants With Dry Eye Disease | Rudacure | Phase 2 | Not yet recruiting | Dry Eye | 200 | clinicaltrials.gov | |
| June 3, 2026 | NCT07623382 | Human Umbilical Cord Mesenchymal Stem Cell-derived Small Extracellular Vesicles for the Treatment of Dry Eye Disease | The First Affiliated Hospital of Xiamen University | Early phase 1 | Recruiting | Dry Eye Disease, Umbilical Cord Mesenchymal Stem Cell-derived Small Extracellular Vesicles | 20 | China | clinicaltrials.gov |
| June 2, 2026 | NCT07621952 | Meibomian Gland Changes in Ocular Prosthesis Users | Instituto de Oftalmología Fundación Conde de Valenciana | Observational | Completed | Dry Eye, Meibomian Gland Dysfunction (Disorder), Anophthalmic Socket Syndrome, Ocular Prostheses | 20 | Mexico | clinicaltrials.gov |
| June 1, 2026 | NCT07618364 | The Effect of Rinsing on Ocular Inflammation and Symptoms in Patients With Dry Eye Disease | Rinsada | Not applicable | Recruiting | Dry Eye Syndromes, Dry Eye, Ocular Surface Disease | 33 | United States | clinicaltrials.gov |
| June 1, 2026 | NCT07618169 | Comparative Effects of USB-Powered Warm Compress and Self-Heating Eye Mask in the Management of Meibomian Gland Dysfunction | King Saud University | Not applicable | Completed | Dry Eye, MGD-Meibomian Gland Dysfunction | 15 | Saudi Arabia | clinicaltrials.gov |
| May 29, 2026 | NCT07614347 | Development and Evaluation of an Intelligent Diagnosis System for Dry Eye Disease Based on Confocal Microscopy | Capital Medical University | Observational | Not yet recruiting | Dry Eye | 75 | clinicaltrials.gov | |
| May 26, 2026 | NCT07606625 | Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment | University of California, Berkeley | Phase 4 | Recruiting | Dry Eye, Meibomian Gland Dysfunction | 65 | United States | clinicaltrials.gov |
| May 26, 2026 | NCT07605572 | Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity | Attikon Hospital | Observational | Recruiting | Dry Eye Disease (DED), Diabete Mellitus, GLP-1, Ocular Surface, Diabetes Type 2, Cornea | 100 | Greece | clinicaltrials.gov |
| May 18, 2026 | NCT07593885 | A Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to... | Dr. Gerhard Mann chem.-pharm. Fabrik GmbH | Not applicable | Recruiting | Dry Eye | 160 | Germany | clinicaltrials.gov |
| May 18, 2026 | NCT07593404 | Evaluation of a Novel Ocular Lubricating Eye Drop | Pleryon Therapeutics (Hangzhou) Limited | Not applicable | Recruiting | Dry Eye Syndrome (DES) | 40 | Canada | clinicaltrials.gov |
| May 14, 2026 | NCT07588074 | Tolerability Comparison of Flarex to Lotemax SM | Harrow Inc | Phase 4 | Completed | Ocular Inflammation, Keratoconjunctivitis, Dry Eye Disease (DED), Post-operative Complications, Kerato Conjunctivitis... | 40 | United States | clinicaltrials.gov |
| May 12, 2026 | NCT07581548 | Evaluation of the Effectiveness of Three Tear Substitute Formulations in Postoperative Discomfort After Cataract Surgery | Democritus University of Thrace | Observational | Not yet recruiting | Cataract, Dry Eye | 300 | Greece | clinicaltrials.gov |
| May 11, 2026 | NCT07579156 | TearCare in Young Adults | University of Alabama at Birmingham | Not applicable | Not yet recruiting | Meibomian Gland Dysfunction (Disorder) | 45 | United States | clinicaltrials.gov |
| May 11, 2026 | NCT07579130 | Comparative Assessment of Lipid Layer Thickness Measurements | Indiana University | Observational | Recruiting | Dry Eye | 50 | United States | clinicaltrials.gov |
| May 5, 2026 | NCT07566975 | Real-World Assessment of VEVYE® for Short-Term Symptom and Sign Improvement of Dry Eye Disease in a Neuro-Ophthalmology Clinic: A 6-Month... | Neuro-Ophthalmology of Texas | Observational | Recruiting | Dry Eye | 50 | United States | clinicaltrials.gov |
| May 1, 2026 | NCT07560735 | Clinical Evaluation of Lifitegrast Ophthalmic Solution 5.0% in Dry Eye Disease Using In Vivo Confocal Microscopy | Toyos Clinic | Phase 4 | Not yet recruiting | Dry Eye | 30 | United States | clinicaltrials.gov |
| April 28, 2026 | NCT07554937 | Blinking Exercise Study | St. Joseph's Healthcare Hamilton | Not applicable | Not yet recruiting | Dry Eye Disease (DED), Glaucoma | 45 | clinicaltrials.gov | |
| April 28, 2026 | NCT07554911 | Detection and Optimization of Treatment of Severe Cases of Dry Eye Disease | Singapore National Eye Centre | Observational | Recruiting | Dry Eye | 200 | Singapore | clinicaltrials.gov |
| April 28, 2026 | NCT07553455 | Vevye + Flarex Combination Therapy for Dry Eye | Canyon City Eyecare | Phase 4 | Enrolling by invitation | Dry Eye | 60 | United States | clinicaltrials.gov |
| April 27, 2026 | NCT07551843 | Comparative Effects of Autologous Serum, Umbilical Cord Blood-Derived Drops, and Platelet Lysate on Ocular Surface Parameters | G.Gennimatas General Hospital | Phase 1/2 | Completed | Dry Eye Disease (DED) | 80 | Greece | clinicaltrials.gov |
| April 23, 2026 | NCT07548632 | A Clinical Study Evaluating Licaminlimab for Dry Eye Disease | Oculis | Phase 2/3 | Active not recruiting | Dry Eye Disease (DED) | 160 | United States | clinicaltrials.gov |
| April 21, 2026 | NCT07540884 | Evaluation of Tears Naturale® Free and Tears Naturale® II Lubricant Eye Drops | Alcon Research | Not applicable | Completed | Dry Eye Disease | 132 | Canada | clinicaltrials.gov |
| April 14, 2026 | NCT07529899 | Evaluate the Efficacy and Safety of Amnion Membrane Disc Allograft vs Standard of Care in Participants With Dry Eye Disease | Cellution Biologics | Phase 4 | Withdrawn | Dry Eye Disease (DED) | 0 | clinicaltrials.gov | |
| April 13, 2026 | NCT07525336 | Effect of Dry Eye Disease on Accuracy of Intraocular Lens Power Calculation Before Phacoemulsification | Assiut University | Observational | Not yet recruiting | Dry Eye Disease (DED), Cataract (Post-operative Cataract Surgery Follow-up) | 100 | clinicaltrials.gov | |
| April 13, 2026 | NCT07524725 | Effect of Behavioral Intervention (Baduanjin Alone or Laughter Exercise Plus Artificial Tears) Versus Artificial Tear on Dry Eye Disease: a... | Zhongshan Ophthalmic Center, Sun Yat-sen University | Not applicable | Not yet recruiting | Dry Eye Disease (DED) | 540 | clinicaltrials.gov | |
| April 13, 2026 | NCT07521748 | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of RC017 Ophthalmic Ointment Following Single and Multiple Doses... | Nanjing Reju Therapeutics Co., Ltd | Phase 1 | Not yet recruiting | Dry Eye | 24 | clinicaltrials.gov | |
| April 3, 2026 | NCT07510620 | Single-Arm Study of a Treatment for Dry Eye in People Who Struggle to Wear Contact Lenses | Vision Innovation Centers of Pennsylvania, LLC d/b/a Eye Care Specialists | Phase 4 | Recruiting | Dry Eye | 30 | United States | clinicaltrials.gov |
| March 31, 2026 | NCT07503886 | An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease | Dompé Farmaceutici S.p.A | Phase 2 | Recruiting | Dry Eye Disease (DED) | 417 | United States | clinicaltrials.gov |
| March 30, 2026 | NCT07499193 | Study of Blinking as a Function of Tear Film Quality | Essilor International | Not applicable | Not yet recruiting | Dry Eye | 60 | France | clinicaltrials.gov |
| March 24, 2026 | NCT07490535 | This is a Single Center, Open-label Prospective Study to Evaluate the Effect of Xiidra® (Lifitegrast Ophthalmic Solution 5.0%) on Tear Film... | Pittsburgh Research Institute | Phase 4 | Not yet recruiting | Ocular Surface Disease, Dry Eye Syndrome (DES) | 36 | United States | clinicaltrials.gov |
| March 13, 2026 | NCT07469865 | Efficacy and Safety of 20% and 100% Autologous Serum Eye Drops in Patients With Severe Dry Eye Disease (AST) | University Hospital, Ghent | Not applicable | Completed | Dry Eye Disease | 46 | Belgium | clinicaltrials.gov |
| March 9, 2026 | NCT07457021 | A Study to Evaluate the Safety and Effectiveness of Perfluorohexyloctane Eye Drops on Treatment of Dry Eye Disease (DED) Related to... | Xiamen Ophthalmology Center Affiliated to Xiamen University | Observational | Not yet recruiting | Dry Eye Disease | 2,000 | China | clinicaltrials.gov |
| March 5, 2026 | NCT07453212 | Microbiome-Focused Food Supplement for Evaporative Dry Eye Due to Meibomian Gland Dysfunction | Varol TUNALI | Not applicable | Enrolling by invitation | Dry Eye, Evaporative Dry Eye Disease, Meibomian Gland Dysfunction (Disorder) | 130 | Turkey (Türkiye) | clinicaltrials.gov |
| February 24, 2026 | NCT07430735 | BriTer Eyez Moisture Vue™ On-Demand Disposable Moisture Chamber | University of Rochester | Not applicable | Recruiting | Dry Eye Disease (DED) | 35 | United States | clinicaltrials.gov |
| February 24, 2026 | NCT07430137 | Blink Reminders and Meibomian Gland Loss in Digital Screen Users | Asociación para Evitar la Ceguera en México | Not applicable | Not yet recruiting | Dry Eye Syndromes, Meibomian Gland Dysfunction (Disorder) | 28 | clinicaltrials.gov | |
| February 19, 2026 | NCT07419776 | The Effect Of Polycystic Ovarian Syndrome Treatment On Ocular Surface. | Cairo University | Observational | Completed | Poly Cystic Ovary Syndrome | 90 | Egypt | clinicaltrials.gov |
| February 17, 2026 | NCT07415330 | Lacrima VR for Dry Eye Disease and Meibomian Gland Dysfunction | Demaod Ltd | Not applicable | Not yet recruiting | Dry Eye, Dry Eye Syndromes | 20 | clinicaltrials.gov | |
| February 17, 2026 | NCT07413172 | Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye | University of Miami | Phase 2 | Recruiting | Dry Eye, Eye Diseases, Eyes Dry Chronic | 20 | United States | clinicaltrials.gov |
| February 17, 2026 | NCT07412860 | Clinical Investigation Between the Topical Administration of a Tear Substitute With Ancillary Medicinal Substance and Hyaluronic Acid 0.3%... | FB Vision S.p.A | Not applicable | Recruiting | Dry Eye Syndromes, Dry Eye Disease (DED) | 74 | Italy | clinicaltrials.gov |
| February 12, 2026 | NCT07407101 | Impact of Filtration on Autologous Serum Eye Drops | University Hospital, Limoges | Not applicable | Completed | Dry Eye Syndrome (DES) | 10 | France | clinicaltrials.gov |
| February 9, 2026 | NCT07397949 | Rebamipide Versus Diquafosol for Perioperative Dry Eye in Cataract Surgery | Samsung Medical Center | Phase 4 | Not yet recruiting | Dry Eye Disease (DED), Cataract | 60 | South Korea | clinicaltrials.gov |
| February 9, 2026 | NCT07397936 | Rebamipide Versus Diquafosol and Cyclosporine for Perioperative Dry Eye in Cataract Surgery | Samsung Medical Center | Phase 4 | Completed | Dry Eye Disease (DED), Cataract | 56 | South Korea | clinicaltrials.gov |
| February 9, 2026 | NCT07396441 | Supplementary Kelulut Honey Therapy in Juvenile Open-Angle Glaucoma: Effects on IL-6, RNFL and Dry Eye | Universiti Sains Malaysia | Phase 4 | Recruiting | Juvenile Open Angle Glaucoma, Dry Eye Disease (DED), Interleukin 6, Retinal Nerve Fiber Layer Thickness, HbA1c Level | 60 | Malaysia | clinicaltrials.gov |
| February 6, 2026 | NCT07392307 | Association Between Dry Eye Disease and Diabetic Macular Edema | Sohag University | Observational | Not yet recruiting | Dry Eye Disease (DED) , Diabetic Macular Edema | 50 | Egypt | clinicaltrials.gov |
| January 27, 2026 | NCT07369375 | Efficacy and Safety of VMX Eye Drops for Dry Eye Disease | VISUfarma SpA | Not applicable | Not yet recruiting | Dry Eye Disease (DED) | 76 | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| Superior University | 8 | April 6, 2025 |
| Southern College of Optometry | 7 | October 28, 2026 |
| Beijing Tongren Hospital | 5 | October 1, 2026 |
| Assiut University | 4 | September 25, 2026 |
| Vance Thompson Vision | 4 | August 27, 2026 |
| Bausch & Lomb Incorporated | 4 | August 21, 2026 |
| Cairo University | 4 | February 19, 2026 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 4 | January 14, 2026 |
| Eye & ENT Hospital of Fudan University | 3 | November 2, 2026 |
| The Hong Kong Polytechnic University | 3 | September 25, 2026 |
| Alcon Research | 3 | August 17, 2026 |
| Zhongshan Ophthalmic Center, Sun Yat-sen University | 3 | July 15, 2026 |
| Instituto de Oftalmología Fundación Conde de Valenciana | 3 | June 26, 2026 |
| Toyos Clinic | 3 | May 1, 2026 |
| Singapore National Eye Centre | 3 | April 28, 2026 |
| Grigore T. Popa University of Medicine and Pharmacy | 3 | January 12, 2026 |
| Laboratoires Thea | 3 | November 18, 2025 |
| China Medical University Hospital | 3 | August 21, 2025 |
| Ocular Aesthetics, LLC dba Ocular Clinical Trials | 2 | October 29, 2026 |
| University of California, Berkeley | 2 | October 22, 2026 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Not applicable | 95 | November 5, 2026 |
| Phase 4 | 54 | October 28, 2026 |
| Observational | 37 | November 9, 2026 |
| Phase 2 | 23 | October 1, 2026 |
| Phase 3 | 11 | July 31, 2026 |
| Phase 1 | 6 | October 29, 2026 |
| Early phase 1 | 5 | November 2, 2026 |
| Phase 1/2 | 3 | April 27, 2026 |
| Phase 2/3 | 1 | April 23, 2026 |
By country
| Country | New trials | Latest |
|---|---|---|
| United States | 60 | November 9, 2026 |
| China | 27 | October 1, 2026 |
| Egypt | 12 | October 27, 2026 |
| Taiwan | 11 | August 21, 2025 |
| Pakistan | 9 | April 23, 2025 |
| France | 8 | October 14, 2026 |
| South Korea | 8 | September 9, 2026 |
| Italy | 7 | February 17, 2026 |
| Turkey (Türkiye) | 6 | August 27, 2026 |
| Austria | 5 | September 9, 2026 |
| Mexico | 5 | July 23, 2026 |
| Spain | 5 | July 20, 2026 |
| Hong Kong | 4 | September 25, 2026 |
| Greece | 4 | May 26, 2026 |
| Romania | 4 | January 12, 2026 |
| Australia | 4 | November 20, 2025 |
| Saudi Arabia | 3 | November 5, 2026 |
| Germany | 3 | October 14, 2026 |
| Poland | 3 | October 14, 2026 |
| Canada | 3 | May 18, 2026 |
| Singapore | 3 | April 28, 2026 |
| Belgium | 2 | October 14, 2026 |
| Netherlands | 2 | October 14, 2026 |
| Malaysia | 2 | February 9, 2026 |
| Croatia | 2 | May 25, 2025 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.